Vladimir Jurisic Selected Research

Vladimir Jurisic Research Topics

Disease

11	Neoplasms (Cancer) 01/2020 - 02/2006
6	Breast Neoplasms (Breast Cancer) 03/2021 - 04/2010
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2021 - 12/2012
2	Carcinoma (Carcinomatosis) 01/2017 - 09/2015
2	Leukemia 09/2010 - 10/2006
2	Primary Myelofibrosis (Myelosclerosis) 01/2008 - 10/2006
2	Radicular Cyst 01/2007 - 01/2007
2	Cysts 01/2007 - 01/2007
1	Endometrial Hyperplasia 05/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2019
1	Gastrointestinal Hemorrhage (Hematochezia) 01/2016
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2016
1	Polyps 03/2015
1	Parkinson Disease (Parkinson's Disease) 09/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2012
1	Alzheimer Disease (Alzheimer's Disease) 09/2012
1	Dementia (Dementias) 09/2012
1	Stroke (Strokes) 09/2012
1	Hemolysis 08/2012
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 08/2012
1	Anemia 08/2012
1	Odontogenic Tumors (Dental Tissue Neoplasm) 04/2012
1	Communicable Diseases (Infectious Diseases) 04/2012
1	Melanoma (Melanoma, Malignant) 04/2012
1	Hypersensitivity (Allergy) 04/2012
1	Hodgkin Disease (Hodgkin's Disease) 04/2012
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2012
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2012
1	Necrosis 02/2011
1	Systemic Scleroderma (Systemic Sclerosis) 02/2011
1	Proteinuria 02/2011
1	Plasmacytoma 01/2010
1	Pathologic Complete Response 10/2009
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 01/2008
1	Fibrosis (Cirrhosis) 01/2008
1	Splenomegaly 01/2008

Drug/Important Bio-Agent (IBA)

5	EnzymesIBA 01/2015 - 04/2010
4	CytokinesIBA 01/2020 - 02/2006
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2015 - 01/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008 - 02/2006
3	ErbB Receptors (EGF Receptor)IBA 04/2021 - 12/2012
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2014 - 04/2010
2	Peptide Hydrolases (Proteases)FDA Link 01/2014 - 04/2010
2	pro-matrix metalloproteinase 9IBA 01/2014 - 04/2010
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2014 - 04/2010
2	Tumor Biomarkers (Tumor Markers)IBA 01/2014 - 04/2010
2	progelatinaseIBA 01/2014 - 04/2010
2	DNA (Deoxyribonucleic Acid)IBA 11/2013 - 01/2012
2	AutoantibodiesIBA 08/2012 - 01/2012
2	Rituximab (Mabthera)FDA Link 08/2012 - 10/2009
2	Interleukin-2 (IL2)IBA 04/2012 - 01/2010
2	Immunoglobulin G (IgG)IBA 01/2012 - 02/2011
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 02/2011 - 02/2006
2	Proteins (Proteins, Gene)FDA Link 01/2007 - 01/2007
1	Cyclin D1IBA 03/2021
1	Peptides (Polypeptides)IBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 09/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2019
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 09/2019
1	Estrogen ReceptorsIBA 11/2014
1	human ERBB2 proteinIBA 11/2014
1	Steroid Receptors (Steroid Receptor)IBA 01/2014
1	Phenobarbital (Luminal)FDA Link 01/2014
1	ParaffinIBA 11/2013
1	Formaldehyde (Formol)FDA Link 11/2013
1	Sepharose (Agarose)IBA 11/2013
1	CatalaseIBA 06/2013
1	Superoxide DismutaseIBA 06/2013
1	Estrogens (Estrogen)FDA Link 09/2012
1	Neuroprotective AgentsIBA 09/2012
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2012
1	Methylprednisolone FDA LinkGeneric 08/2012
1	Immunoglobulins (Immunoglobulin)IBA 08/2012
1	Hemoglobins (Hemoglobin)IBA 08/2012
1	Natural Killer Cell ReceptorsIBA 04/2012
1	Biological ProductsIBA 04/2012
1	AutoantigensIBA 01/2012
1	ImmunosorbentsIBA 01/2012
1	Thalidomide (Thalomid)FDA Link 02/2011
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2011
1	Methotrexate (Mexate)FDA LinkGeneric 02/2011
1	ParaproteinsIBA 02/2011
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2011
1	Penicillamine (Cuprimine)FDA Link 02/2011
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2010
1	SteroidsIBA 04/2010
1	ErbB-2 ReceptorIBA 04/2010
1	Keratins (Keratin)IBA 01/2010
1	Parathyroid Hormone (Parathormone)IBA 01/2008

Therapy/Procedure

7	Therapeutics 04/2021 - 04/2012
1	Lymph Node Excision (Lymph Node Dissection) 01/2017
1	Pancreaticoduodenectomy 01/2017
1	Radiotherapy 01/2016
1	Operative Surgical Procedures 09/2015
1	Aftercare (After-Treatment) 08/2012
1	Transplantation 04/2012
1	Immunotherapy 04/2012
1	CHOP protocol (VDCP protocol) 10/2009